Olmiere Injection

Adult administration

Dissolve 5 mL of injection-grade distilled water gently and mix within 5 minutes with 500 to 1,000 mL of intravenous glucose injection solution, saline solution, or similar infusion for intravenous use, administered as a drip once daily.

Child administration

Dissolve 5 mL of injection-grade distilled water gently and mix within 5 minutes with 500 to 1,000 mL of intravenous glucose injection solution, saline solution, or similar infusion for intravenous use, administered once daily.

This medication should be used with caution in women during the first 3 months of pregnancy or those who may become pregnant, as vitamin A should not be administered in doses exceeding 5,000 IU per day due to the risk of congenital malformations. Patients with hypersensitivity to any of the components of this medication or hemophilia should not use it. Caution is advised for patients with hypercalcemia, impaired kidney function, children under 11 years old, patients with a history of allergies, and those with a history of drug hypersensitivity. Overdose may lead to hypersensitivity reactions to vitamins A and D or severe allergic reactions such as anaphylaxis, thus symptoms should be closely monitored. If used for more than a few weeks, it is necessary to check for accumulations of vitamins A and D in the body. This medication may interact with certain drugs, so caution is required when used alongside other medications. Pregnant or breastfeeding women should administer it cautiously to avoid side effects due to vitamin overdose. Safety and efficacy in children under 11 years have not been established, so it is advisable to avoid use. Elderly patients may require dosage adjustments due to potentially decreased bodily functions. This medication may affect urine test results, so it should be considered during testing. Unused portions should not be reused, and careful storage should be maintained to avoid light and freezing.

Serious side effects

• Hypotension
• altered consciousness
• difficulty breathing
• shock
• symptoms of anaphylaxis

Mild side effects

• Hypotension, altered consciousness, cyanosis, nausea, chest discomfort, facial flushing, itching, sweating
• Worsening of hypercalcemia, risk of decreased kidney function, dizziness, fainting
• Influence on clinical test results (interference with urine glucose detection, false negative reactions, yellow discoloration of urine)

This medication should be stored in a sealed container to avoid contact with air and kept at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness.

Appearance

A freeze-dried injection in a brown vial containing yellow powder

Package unit

10 vials